3. Steps to Take if You Use Ranitidine
According to the FDA website, individuals who take ranitidine should follow the recall instructions provided by Sandoz. The FDA states that while they investigate the contamination, patients can continue to take ranitidine from lots not included in the recall. Not all ranitidine products are included in this recall. Therefore, patients who rely on this medication can continue to find this drug. Those who would prefer to switch to a different type of acid blocker can contact their doctors for a recommendation.
2. What Is a Voluntary Recall?
When a drug manufacturer voluntarily decides to remove a drug product from the market due to concerns regarding safety or effectiveness, it is known as a recall. The FDA lists three classifications of recalls. First, Class I refers to a dangerous or defective product that may cause severe health issues or death. Next, Class II represents products that may cause a temporary health problem or pose a slight threat of a serious nature. Finally, Class III recalls are for products that are unlikely to cause adverse health reactions, but that violate labeling or manufacturing laws.
1. Other Drugs Tainted by NDMA
Ranitidine is not the first medication to test at unacceptable levels for NDMA. Earlier this year, pharmaceutical companies recalled certain lots of three blood pressure medications. The drugs involved are losartan, valsartan, and irbesartan. These medications are angiotensin II receptor blockers (ARBs). ARBs lower blood pressure through their effects on blood vessels. The FDA warns consumers not to discontinue taking their blood pressure medications without the supervision of a physician. So far, there have been no reports of NDMA-related injury to patients taking these medications.Related: 10 Foods That Help Decrease Acid Reflux